Your browser doesn't support javascript.
loading
Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer.
Xiang, Yi; Lu, Xiao Juan; Sun, Yi Hang; Liu, Xia; Wu, Yan Yang; Rao, Hui; Que, Qiu Yang; Xiao, Qi; Zhu, Rui; Feng, Xiao Fei; Lai, Wei Ling; Zou, Xiao Huan; Wang, Ying; Qiu, Song; Huang, Li; Shi, Hua Qiu; Wang, Xiang Cai.
Afiliação
  • Xiang Y; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Lu XJ; Department of Oncology, The People's Hospital of Leshan, Leshan, China.
  • Sun YH; School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Liu X; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Wu YY; First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Rao H; First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Que QY; First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Xiao Q; Jiangkou Town Central Health Center, Ganzhou, China.
  • Zhu R; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Feng XF; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Lai WL; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Zou XH; Department of Critical Care Medicine, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Wang Y; First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Qiu S; First Clinical Medical College, Gannan Medical University, Ganzhou, China.
  • Huang L; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
  • Shi HQ; These authors contributed equally to this work.
  • Wang XC; Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.
World J Oncol ; 13(5): 320-324, 2022 Oct.
Article em En | MEDLINE | ID: mdl-36406194
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China